Skip to Main Content

Author Details

Aarthi Shenoy
MedStar Washington Hospital Center
2006
35
15
PMIDPaper TitleJournal TitlePublished Year
38009954COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial.Microbiol Spectr2024
37131659Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.medRxiv2023
37659419Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study.Lancet Microbe2023
37534607Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials.Transfusion2023
37342408Development and Validation of an Algorithm for Thrombosis with Thrombocytopenia Syndrome (TTS) at Unusual Sites.Int J Gen Med2023
35104245Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection.JCI Insight2022
35353960Early Outpatient Treatment for Covid-19 with Convalescent Plasma.N Engl J Med2022
35352362How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Transfusion2022
35780813Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial.Chest2022
33482025Early mortality benefit with COVID-19 convalescent plasma: a matched control study.Br J Haematol2021
34981068Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.medRxiv2021
34097758Single-Center Analysis of Characteristics and Outcomes of De Novo, Concurrent, and Transformed Diffuse Large B-Cell Lymphoma.Oncologist2021
32875042Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases.JAAD Case Rep2020
32105293Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.JAMA Oncol2020
30936058Long-term outcomes in myelodysplastic syndrome patients treated with alemtuzumab.Blood Adv2019
30763649The impact of environmental ultraviolet exposure on the clinical course of mycosis fungoides.J Am Acad Dermatol2019
29741774Management of post-transplant lymphoproliferative disorders.Br J Haematol2018
30083561Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue.J Investig Med High Impact Case Rep2018
28509395DA-EPOCH-R for post-transplant lymphoproliferative disorders.Eur J Haematol2017
25387087Clinical and biological predictors of outcome following relapse of CML post-allo-SCT.Bone Marrow Transplant2015
24355282Hypersensitivity to romidepsin.J Am Acad Dermatol2014
22524974Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na.Leuk Res2012
21421838Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.Blood2011
21684344Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.Biol Blood Marrow Transplant2011
21041705Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.J Clin Oncol2010
19203730Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies.Biol Blood Marrow Transplant2009
19539222Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantation.Biol Blood Marrow Transplant2009
18721771Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination.Biol Blood Marrow Transplant2008
16990594Functional characterization of natural telomerase mutations found in patients with hematologic disorders.Blood2007
17448923Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation.Biol Blood Marrow Transplant2007
17448910Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation.Biol Blood Marrow Transplant2007
16799339Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.J Immunother2006
17148595Recovery of spermatogenesis after total-body irradiation.Blood2006
17162207Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.Biol Blood Marrow Transplant2006
17162214T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.Biol Blood Marrow Transplant2006
  • 1 - 35 of 35

Recommended Authors

Yale Cancer Center and Yale School of Medicine
Career Start Year 2018
Number of shared co-authors 1
School of Clinical Sciences at Monash Health, Monash University
Career Start Year 2011
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2009
Number of shared co-authors 2
The University of Texas Southwestern Medical Center
Career Start Year 2009
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 0
University of Manitoba
Career Start Year 2005
Number of shared co-authors 1
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 1
Oregon Health Sciences University
Career Start Year 2002
Number of shared co-authors 2
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 0
Merck & Co.
Career Start Year 1998
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1997
Number of shared co-authors 0
Medical Governance Research Institute
Career Start Year 1997
Number of shared co-authors 0
Dana Farber Cancer Institute/Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 0
Duke University Medical Center
Career Start Year 1995
Number of shared co-authors 3
Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 1
Moffitt Cancer Center
Career Start Year 1992
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1990
Number of shared co-authors 5
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 0
University Hospitals of Cleveland
Career Start Year 1988
Number of shared co-authors 1
Center for Biologics Evaluation and Research
Career Start Year 1988
Number of shared co-authors 4
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 2
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Career Start Year 1986
Number of shared co-authors 5
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1986
Number of shared co-authors 3
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 3
University of Leipzig
Career Start Year 1982
Number of shared co-authors 0
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 0
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 1
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 1978
Number of shared co-authors 1

Collaborators

Johns Hopkins Bloomberg School of Public Health
Co-authored papers 8
Johns Hopkins School of Medicine, Johns Hopkins University
Co-authored papers 8
Johns Hopkins School of Medicine, Johns Hopkins University
Co-authored papers 8
Johns Hopkins University School of Medicine
Co-authored papers 7
Johns Hopkins University School of Medicine
Co-authored papers 7
University of New Mexico
Co-authored papers 7
Co-authored papers 7
Mayo Clinic Hospital
Co-authored papers 6
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
Co-authored papers 6
David Geffen School of Medicine, University of California los angeles
Co-authored papers 6
Co-authored papers 5
University of Rochester Medical Center
Co-authored papers 5
Johns Hopkins University School of Medicine
Co-authored papers 4
Co-authored papers 4
National Heart Lung and Blood Institute Division of Intramural Research
Co-authored papers 4
Wilmer Eye Institute, Johns Hopkins Medicine School of Medicine
Co-authored papers 3
University of Pittsburgh
Co-authored papers 2
and Blood Institute, National Institutes of Health
Co-authored papers 2
Vanderbilt University School of Medicine
Co-authored papers 1
Louisiana State University Health Sciences Center.
Co-authored papers 1
University of Colorado School of Medicine
Co-authored papers 1
University of Minnesota
Co-authored papers 1
Duke University
Co-authored papers 1
Vanderbilt University
Co-authored papers 1
Sentara Norfolk General Hospital, Eastern Virginia Medical School
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
The Ohio State University Wexner Medical Center
Co-authored papers 1
University of Washington
Co-authored papers 1
University of Arkansas for Medical Sciences
Co-authored papers 1
University of Colorado School of Medicine
Co-authored papers 1